Epidemiology, treatment patterns, clinical outcomes, and disease burden among patients with immune-mediated thrombotic thrombocytopenic purpura in the United States.

Ayoade Adeyemi Francesca Razakariasa Alexandra Chiorean Rui de Passos Sousa

Published in: Research and practice in thrombosis and haemostasis (2022)

Despite treatment with TPE and immunosuppressants, patients with iTTP have high risk of morbidity and mortality, demonstrating the need for more effective therapies.

Keyphrases

combination therapy